Objective To investigate the expression of insulin-like growth factor 2 mRNA binding protein 1(IGF2BP1)mRNA and patrilineal expression of genetic imprinting gene 10(PEG10)mRNA in endometrial carcinoma(EC)tissues and their correlation with proliferation gene expression and prognosis.Methods A total of 100 EC patients diagnosed and treated in Hubei Institute of Technology Affiliated Maternal and Child Health Hospital from January 2017 to January 2019 were selected.The expression of IGF2BP1 mRNA,PEG 10 mRNA,proliferating cell nuclear antigen(PCNA),cyclin D1,and cyclin dependent kinase 4(CDK4)mRNA were examined by real-time fluorescence quantitative PCR.The expressions of IGF2BP1 and PEG 10 in tissues were detected by immunochemistry,and their correlation were analyzed by Pearson correlation analysis.Kaplan-Meier curve analysis were used to analyze the prognostic differences in EC patients with different IGF2BP1 and PEG 10 expression groups.COX regression was used to analyze the prognostic factors of EC patients.Results The expression levels of IGF2BP1 mRNA(1.84±0.33),PEG10 mRNA(2.12±0.40),PCNA mRNA(3.14±0.42),cyclinD1 mRNA(2.81±0.36)and CDK4 mRNA(2.37±0.34)in EC cancer tissues were higher than those in adjacent tissues(0.78±0.21,0.91±0.25,0.74±0.13,0.67±0.21,0.59±0.18),and the differences were significant(t=25.652～54.588,all P＜0.05).The positive rates of IGF2BP1(70.00％)and PEG 10(72.00％)in cancer tissues were higher than those in adjacent tissues(10.00％,9.00％),and the differences were statistically significant(x2=75.000,82.363,all P＜0.05).The expressions of IGF2BP1 mRNA and PEG10 mRNA in EC tissues were positively correlated with PCNA mRNA,cyclinD1 mRNA,and CDK4 mRNA(r=0.562～0.625,all P＜0.05).There was a significant positive correlation between IGF2BP1 mRNA and PEG10 mRNA expression in EC tissues(r=0.663,P＜0.05).The positive rates of IGF2BP1(86.49％,87.50％)and PEG10(89.19％,90.63％)protein expression in EC cancer tissues with FIGO stage Ⅲ and combined lymph node metastasis were higher than those in FIGO stage Ⅰ-Ⅱ(60.321％,61.90％)and without lymph node metastasis(61.77％,63.24％),and the differences were sttistically significant(x2=6.863～8.608,all P＜0.05).The overall 3-year survival rate of IGF2BP1 positive patients[70.00％(49/70)]was lower than that of IGF2BP1 negative patients[90.00％(27/30)],the overall 3-year survival rate of patients in PEG10 positive patients[69.40(50/72)]was lower than that in PEG10 negative patients[92.86％(26/28)],and the differences were statistically significant(Log rankx2=4.133,5.491,P=0.042,0.019).FIGO stage Ⅲ(OR=1.449,95％CI:1.148～1.830),combined lymph node metastasis(OR=1.442,95％CI:1.124～1.850),IGF2BP1 positive(OR=1.637,95％CI:1.239～2.163),and PEG10 positive(OR=1.576,95％CI:1.136～1.187)were independent risk factors affecting the survival and prognosis of EC patients(all P＜0.05).Conclusion The expressions of IGF2BP1 and PEG 10 in EC were increased,and they were positively correlated with the proliferation gene expression.They may be potential tumor markers for prognostic evaluation of EC.
endometrial carcinomainsulin-like growth factor 2 mRNA binding protein 1patrilineal expression of genetic imprinting gene 10proliferationclinical pathological characteristics
维普
万方数据
